Related references
Note: Only part of the references are listed.Logic-gated approaches to extend the utility of chimeric antigen receptor T-cell technology
Lisa M. Ebert et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2018)
Engrafting human regulatory T cells with a flexible modular chimeric [ antigen receptor technology
Stefanie Koristka et al.
JOURNAL OF AUTOIMMUNITY (2018)
Versatile CAR T-cells for cancer immunotherapy
Fuliang Chu et al.
Wspolczesna Onkologia-Contemporary Oncology (2018)
From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo
Susann Albert et al.
Oncotarget (2018)
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Julien Valton et al.
SCIENTIFIC REPORTS (2018)
Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells
Iulia Diaconu et al.
MOLECULAR THERAPY (2017)
Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells
Dominik Bachmann et al.
Oncotarget (2017)
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
Nicola Mitwasi et al.
ONCOTARGET (2017)
Retargeting of T lymphocytes to PSCA-or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology UniCAR
Anja Feldmann et al.
ONCOTARGET (2017)
Pre-clinical development of gene modification of haematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy
Sarah M. Larson et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform
Susann Albert et al.
ONCOIMMUNOLOGY (2017)
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
D. Sommermeyer et al.
LEUKEMIA (2016)
Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
Paulina J. Paszkiewicz et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts
M. Cartellieri et al.
BLOOD CANCER JOURNAL (2016)
Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigens
Andreas Kirschner et al.
ONCOTARGET (2016)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
Remote control of therapeutic T cells through a small molecule-gated chimeric receptor
Chia-Yung Wu et al.
SCIENCE (2015)
A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy
Brian Philip et al.
BLOOD (2014)
Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: description of a novel modular targeting system
C. Arndt et al.
LEUKEMIA (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Novel Ex Vivo Isolation and Expansion Procedure for Chimeric Antigen Receptor Engrafted Human T Cells
Marc Cartellieri et al.
PLOS ONE (2014)
Redirection of CD4+ and CD8+ T lymphocytes via a Novel Antibody-Based Modular Targeting System Triggers Efficient Killing of PSCA+ Prostate Tumor Cells
Claudia Arndt et al.
PROSTATE (2014)
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Marco L. Davila et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B
Stefanie Koristka et al.
JOURNAL OF AUTOIMMUNITY (2013)
Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective
Thomas C. Wehler et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma
Lihua E. Budde et al.
PLOS ONE (2013)
T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
Marcela V. Maus et al.
CANCER IMMUNOLOGY RESEARCH (2013)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
Retargeting of Human Regulatory T Cells by Single-Chain Bispecific Antibodies
Stefanie Koristka et al.
JOURNAL OF IMMUNOLOGY (2012)
Impact of Epidermal Growth Factor Receptor (EGFR) Cell Surface Expression Levels on Effector Mechanisms of EGFR Antibodies
Stefanie Derer et al.
JOURNAL OF IMMUNOLOGY (2012)
Novel Humanized and Highly Efficient Bispecific Antibodies Mediate Killing of Prostate Stem Cell Antigen-Expressing Tumor Cells by CD8+ and CD4+ T Cells
Anja Feldmann et al.
JOURNAL OF IMMUNOLOGY (2012)
Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
John Scholler et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells
Xiuli Wang et al.
BLOOD (2011)
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Renier J. Brentjens et al.
BLOOD (2011)
Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker module
Slava Stamova et al.
MOLECULAR IMMUNOLOGY (2011)
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
Maria R. Parkhurst et al.
MOLECULAR THERAPY (2011)
A Novel Modular Antigen Delivery System for Immuno Targeting of Human 6-sulfo LacNAc-Positive Blood Dendritic Cells (SlanDCs)
Claudia C. Bippes et al.
PLOS ONE (2011)
Retargeting of T Cells to Prostate Stem Cell Antigen Expressing Tumor Cells: Comparison of Different Antibody Formats
Anja Feldmann et al.
PROSTATE (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
Marc Cartellieri et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
V. Hoyos et al.
LEUKEMIA (2010)
An Improved Bicistronic CD20/tCD34 Vector for Efficient Purification and In Vivo Depletion of Gene-Modified T Cells for Adoptive Immunotherapy
Isabel Vogler et al.
MOLECULAR THERAPY (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation
C Berger et al.
BLOOD (2006)
Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector
AL Szymczak et al.
NATURE BIOTECHNOLOGY (2004)
Share Paper
